RUBEN BRINCKHAUS: Open Payments
NPI 1891708806 · FORTUNA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 23 payments from 8 companies in 2025. Trend: 2023 $75 · 2024 $237 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $145 |
| Novo Nordisk Inc | 6 | $129 |
| Amgen Inc. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
Products named: MOUNJARO, Wegovy, Otezla, JOURNAVX, Ozempic, Qelbree, PURIFIED CORTROPHIN GEL, CREON.
Industry payments across CA — which companies pay providers there.
